SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-214053
Filing Date
2019-08-06
Accepted
2019-08-07 10:26:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d788061dsc13g.htm SC 13G 41884
  Complete submission text file 0001193125-19-214053.txt   43529
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Subject) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87690 | Film No.: 191004219
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1792 BELL TOWER LANE SUITE 222 WESTON FL 33326
Business Address 1792 BELL TOWER LANE SUITE 222 WESTON FL 33326 954-315-3660
CANTEX PHARMACEUTICALS, INC. (Filed by) CIK: 0001374961 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations